<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37490523</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-5994</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Internal medicine journal</Title><ISOAbbreviation>Intern Med J</ISOAbbreviation></Journal><ArticleTitle>Associations between symptoms and functional capacity in patients after COVID-19 infection and community controls.</ArticleTitle><Pagination><StartPage>1540</StartPage><EndPage>1547</EndPage><MedlinePgn>1540-1547</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/imj.16185</ELocationID><Abstract><AbstractText Label="BACKGROUND">Post-acute sequelae of COVID-19 (PASC or 'long COVID') reflect ongoing symptoms, but these are non-specific and common in the wider community. Few reports of PASC have been compared with a control group.</AbstractText><AbstractText Label="AIMS">To compare symptoms and objective impairment of functional capacity in patients with previous COVID-19 infection with uninfected community controls.</AbstractText><AbstractText Label="METHODS">In this community-based, cross-sectional study of functional capacity, 562 patients from Western Melbourne who had recovered from COVID-19 infections in 2021 and 2022 were compared with controls from the same community and tested for functional capacity pre-COVID-19. Functional impairment (&lt;85% of the predicted response) was assessed using the Duke Activity Status Index (DASI) and 6-min walk distance (6MWD) test. A subgroup underwent cardiopulmonary exercise testing before and after exercise training.</AbstractText><AbstractText Label="RESULTS">Of 562 respondents (age 54 &#xb1;&#x2009;12&#x2009;years, 69% women), 389 were symptomatic. Functional impairment (&lt;85% predicted metabolic equivalent of tasks) was documented by DASI in 149 participants (27%), and abnormal 6MWD (&lt;85% predicted) was observed in 14% of the symptomatic participants. Despite fewer risk factors and younger age, patients with COVID-19 had lower functional capacity by 6MWD (P &lt;&#x2009;0.001) and more depression (P &lt;&#x2009;0.001) than controls. In a pilot group of seven participants (age 58 &#xb1;&#x2009;12&#x2009;years, two women, VO<sub>2</sub> 18.9 &#xb1;&#x2009;5.7 mL/kg/min), repeat testing after exercise training showed a 20% increase in peak workload.</AbstractText><AbstractText Label="CONCLUSIONS">Although most participants (69%) had symptoms consistent with long COVID, significant subjective functional impairment was documented in 27% and objective functional impairment in 14%. An exercise training programme might be beneficial for appropriately selected patients.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Internal Medicine Journal published by John Wiley &amp; Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huynh</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wexler</LastName><ForeName>Noah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Western Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Joel</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4227-6577</Identifier><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Leah</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Western Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Felicia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Western Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allwood</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sata</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manca</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howden</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marwick</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><Identifier Source="ORCID">0000-0001-9065-0899</Identifier><AffiliationInfo><Affiliation>Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Western Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>105282</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>105282</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Intern Med J</MedlineTA><NlmUniqueID>101092952</NlmUniqueID><ISSNLinking>1444-0903</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="N">Exercise Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiorespiratory fitness</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">exercise capacity</Keyword><Keyword MajorTopicYN="N">exercise training</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>13</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37490523</ArticleId><ArticleId IdType="pmc">PMC10947235</ArticleId><ArticleId IdType="doi">10.1111/imj.16185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO Coronavirus (COVID&#x2010;19) Dashboard. Available from URL: https://covid19.who.int
</Citation></Reference><Reference><Citation>Al&#x2010;Aly Z, Xie Y, Bowe B. High&#x2010;dimensional characterization of post&#x2010;acute sequelae of COVID&#x2010;19. Nature 2021; 594: 259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I et al. Post&#x2010;covid syndrome in individuals admitted to hospital with covid&#x2010;19: retrospective cohort study. BMJ 2021; 372: n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID&#x2010;19: a systematic review. JAMA Netw Open 2021; 4: e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, Shikotra A, Singapuri A, Sereno M et al. Physical, cognitive, and mental health impacts of COVID&#x2010;19 after hospitalisation (PHOSP&#x2010;COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021; 9: 1275&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock MD, Chew RF, Preiss AJ, Hadley EC, McMurry JA, Leese PJ et al. Long COVID risk and pre&#x2010;COVID vaccination: an EHR&#x2010;based cohort study from the RECOVER program. medRxiv 2022. doi:10.1101/2022.10.06.22280795</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.06.22280795</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC et al. Impact of COVID&#x2010;19 vaccination on the risk of developing long&#x2010;COVID and on existing long&#x2010;COVID symptoms: a systematic review. EClinicalMedicine 2022; 53: 101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid&#x2010;19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021; 372: n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>DePace NL, Colombo J. Long&#x2010;COVID syndrome and the cardiovascular system: a review of neurocardiologic effects on multiple systems. Curr Cardiol Rep 2022; 24: 1711&#x2013;1726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9524329</ArticleId><ArticleId IdType="pubmed">36178611</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 2022; 132: e161167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistella LR, Imamura M, De Pretto LR, Van Cauwenbergh S, Delgado Ramos V, Saemy Tome Uchiyama S et al. Long&#x2010;term functioning status of COVID&#x2010;19 survivors: a prospective observational evaluation of a cohort of patients surviving hospitalisation. BMJ Open 2022; 12: e057246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9334693</ArticleId><ArticleId IdType="pubmed">35896292</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA 2020; 324: 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID&#x2010;19: JACC review topic of the week. J Am Coll Cardiol 2020; 76: 1244&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID&#x2010;19). JAMA Cardiol 2020; 5: 1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>
NSW Health
. Long COVID. Available from URL: https://www.nsw.gov.au/covid-19/testing-managing/long-covid
</Citation></Reference><Reference><Citation>Yang H, Negishi K, Wang Y, Nolan M, Marwick TH. Imaging&#x2010;guided cardioprotective treatment in a community elderly population of stage B heart failure. JACC Cardiovasc Imaging 2017; 10: 217&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">28279368</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter E, Stephenson G, Harris J, Wright L, Marwick TH. Screening&#x2010;guided spironolactone treatment of subclinical left ventricular dysfunction for heart failure prevention in at&#x2010;risk patients. Eur J Heart Fail 2022; 24: 620&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">35014128</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrom D, Elston L, Washington J, Prettyjohns M, Cann K, Myles S et al. Effectiveness of tests to detect the presence of SARS&#x2010;CoV&#x2010;2 virus, and antibodies to SARS&#x2010;CoV&#x2010;2, to inform COVID&#x2010;19 diagnosis: a rapid systematic review. BMJ Evid Based Med 2022; 27: 33&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">33004426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ&#x2010;9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson J, Iezzi A, Khan MA, Maxwell A. Validity and reliability of the Assessment of Quality of Life (AQoL)&#x2010;8D multi&#x2010;attribute utility instrument. Patient 2014; 7: 85&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929769</ArticleId><ArticleId IdType="pubmed">24271592</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six&#x2010;minute walk test. Am J Respir Crit Care Med 2002; 166: 111&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM et al. A brief self&#x2010;administered questionnaire to determine functional capacity (The Duke Activity Status Index). Am J Cardiol 1989; 64: 651&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">2782256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI et al. Prediction of mortality and morbidity with a 6&#x2010;minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993; 270: 1702&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">8411500</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LJ, Olson MB, Kip K, Kelsey SF, Johnson BD, Mark DB et al. The value of estimated functional capacity in estimating outcome: results from the NHBLI&#x2010;Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006; 47: S36&#x2013;S43.</Citation><ArticleIdList><ArticleId IdType="pubmed">16458169</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS et al. The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 2005; 353: 468&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">16079370</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova C, Celli BR, Barria P, Casas A, Cote C, de Torres JP et al. The 6&#x2010;min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J 2011; 37: 150&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">20525717</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillon HT, Saner NJ, Ilsley T, Kliman D, Spencer A, Avery S et al. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi&#x2010;faceted exercise intervention: the ALLO&#x2010;Active trial protocol. BMC Cancer 2022; 22: 898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383666</ArticleId><ArticleId IdType="pubmed">35978289</ArticleId></ArticleIdList></Reference><Reference><Citation>Belli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S et al. Low physical functioning and impaired performance of activities of daily life in COVID&#x2010;19 patients who survived hospitalisation. Eur Respir J 2020; 56: 2002096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7411272</ArticleId><ArticleId IdType="pubmed">32764112</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuven E, Sianesi B. PSMATCH2: Stata Module to Perform Full Mahalanobis and Propensity Score Matching, Common Support Graphing, and Covariate Imbalance Testing. Statistical Software Components S432001, Boston College Department of Economics, revised 01 Feb 2018; 2003.</Citation></Reference><Reference><Citation>Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA et al. Use of cardiopulmonary exercise testing to evaluate long COVID&#x2010;19 symptoms in adults: a systematic review and meta&#x2010;analysis. JAMA Netw Open 2022; 5: e2236057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul CB, Edvardsen A, Follestad T, Trebinjac D, Ankerstjerne OAW, Bronstad E et al. Changes in cardiopulmonary exercise capacity and limitations 3&#x2010;12 months after COVID&#x2010;19. Eur Respir J 2023; 61: 2200745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515478</ArticleId><ArticleId IdType="pubmed">36137587</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost AE, Langleben D, Oudiz R, Hill N, Horn E, McLaughlin V et al. The 6&#x2010;min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascul Pharmacol 2005; 43: 36&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">15890561</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med 2021; 27: 601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudofker EW, Parker H, Cornwell WK 3rd. An exercise prescription as a novel management strategy for treatment of Long COVID. JACC Case Rep 2022; 4: 1344&#x2013;1347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9580598</ArticleId><ArticleId IdType="pubmed">36278147</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and Long COVID: a cross&#x2010;sectional study. Int J Environ Res Public Health 2022; 19: 5093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management. NICE Guideline [NG206]. 2021; 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>